IMPEDIMED LIMITED (IPD)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
IPD - IMPEDIMED LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -0.01
Index:
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.059
23 Mar |
OPEN $0.06 |
HIGH $0.06 |
957,901 LOW $0.06 |
-0.002| TARGET | |||||
|
|||||
| OTHER COMPANIES IN THE SAME SECTOR | |||
| ELX . PGC . AHZ . COH . FPH . LHC . NAN . RMD . SOM . HLA . MX1 . CAT . VHT . ONE . IDX . PME . CSX . 4DX . BRN . EMV . UBI . LDX . RAP . RVA . MEB . IME . PCK . CMP . CYC . IMR . VTI . OVN . EYE . CGS . CU6 . TRJ . EBR . PEB . AT1 . CBL . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
| Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
|---|---|---|---|---|
| EPS (cps) | xxx | - 1.2 | - 1.1 | xxx |
| DPS (cps) | xxx | 0.0 | 0.0 | xxx |
| EPS Growth | xxx | N/A | N/A | xxx |
| DPS Growth | xxx | N/A | N/A | xxx |
| PE Ratio | xxx | N/A | N/A | xxx |
| Dividend Yield | xxx | N/A | 0.0% | xxx |
| Div Pay Ratio(%) | xxx | N/A | N/A | xxx |
Dividend yield today if purchased 3 years ago: 0.00%
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -1.2 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 10.6 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 2.9 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | -15.7 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -188.09 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -51.92 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -51.81 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -42.78 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -51.92 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | -54.99 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -15.7 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | - |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 0 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 3 M |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 41 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 2.12 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
| Title | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 5.2 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 49.41 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 24 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 8 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | 1 M |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | 0 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
IPD STOCK CHART
FNArena News on IPD
| 1 |
FNArena Corporate Results Monitor – 27-02-2023Feb 27 2023 - Australia |
| 2 |
Australian Broker Call *Extra* Edition – Feb 14, 2023Feb 14 2023 - Daily Market Reports |
| 3 |
Australian Broker Call *Extra* Edition – Feb 10, 2023Feb 10 2023 - Daily Market Reports |
| 4 |
Australian Broker Call *Extra* Edition – Oct 27, 2022Oct 27 2022 - Daily Market Reports |
| 5 |
Australian Broker Call *Extra* Edition – Sep 07, 2022Sep 07 2022 - Daily Market Reports |
Latest Medical Equipment & Devices News
| 1 |
Dr Boreham’s Crucible: SDIMar 16 2023 - Small Caps |
| 2 |
Dr Boreham’s Crucible: CochlearMar 03 2023 - Australia |
| 3 |
Dr Boreham’s Crucible: Imagion BiosystemsFeb 13 2023 - Small Caps |
| 4 |
ResMed: Philips Remains The Big UnknownJan 31 2023 - Australia |
| 5 |
Nanosonics Outlook Remains CloudedJan 24 2023 - Small Caps |
| 6 |
Nanosonics Recovers On Less Negative SentimentNov 29 2022 - Small Caps |
| 7 |
Treasure Chest: Fisher & Paykel HealthcareNov 16 2022 - Treasure Chest |
| 8 |
Dr Boreham’s Crucible: Imricor Medical SystemsOct 17 2022 - Small Caps |
| 9 |
Market Share Gains Key to ResMed’s OutlookAug 15 2022 - Australia |
| 10 |
Dr Boreham’s Crucible: 4D MedicalAug 08 2022 - Small Caps |
